Early volume expansion during diarrhea and relative nephroprotection during subsequent hemolytic uremic syndrome

Arch Pediatr Adolesc Med. 2011 Oct;165(10):884-9. doi: 10.1001/archpediatrics.2011.152. Epub 2011 Jul 22.

Abstract

Objectives: To determine if interventions during the pre-hemolytic uremic syndrome (HUS) diarrhea phase are associated with maintenance of urine output during HUS.

Design: Prospective observational cohort study.

Settings: Eleven pediatric hospitals in the United States and Scotland.

Participants: Children younger than 18 years with diarrhea-associated HUS (hematocrit level <30% with smear evidence of intravascular erythrocyte destruction), thrombocytopenia (platelet count <150 × 10³/mm³), and impaired renal function (serum creatinine concentration > upper limit of reference range for age).

Interventions: Intravenous fluid was given within the first 4 days of the onset of diarrhea.

Outcome measure: Presence or absence of oligoanuria (urine output ≤ 0.5 mL/kg/h for >1 day).

Results: The overall oligoanuric rate of the 50 participants was 68%, but was 84% among those who received no intravenous fluids in the first 4 days of illness. The relative risk of oligoanuria when fluids were not given in this interval was 1.6 (95% confidence interval, 1.1-2.4; P = .02). Children with oligoanuric HUS were given less total intravenous fluid (r = -0.32; P = .02) and sodium (r = -0.27; P = .05) in the first 4 days of illness than those without oligoanuria. In multivariable analysis, the most significant covariate was volume infused, but volume and sodium strongly covaried.

Conclusions: Intravenous volume expansion is an underused intervention that could decrease the frequency of oligoanuric renal failure in patients at risk of HUS.

Publication types

  • Clinical Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acute Kidney Injury / etiology*
  • Acute Kidney Injury / prevention & control
  • Adolescent
  • Child
  • Child, Preschool
  • Diarrhea / complications
  • Diarrhea / microbiology
  • Diarrhea / therapy*
  • Female
  • Fluid Therapy*
  • Hemolytic-Uremic Syndrome / complications
  • Hemolytic-Uremic Syndrome / therapy*
  • Hemolytic-Uremic Syndrome / urine
  • Humans
  • Infant
  • Logistic Models
  • Male
  • Multivariate Analysis
  • Oliguria / etiology*
  • Oliguria / prevention & control*
  • Prospective Studies
  • Treatment Outcome